We are live on ! Find out more
ONCS

OncoSec Medical Incorporated
ONCS

Delisted

ONCS was delisted on the 23rd of June, 2023.

Back to rankings

35 hedge funds and large institutions have $19.2M invested in OncoSec Medical Incorporated in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 10 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 10

14% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 7

3% more funds holding

Funds holding: 34 → 35 (+1)

47% less capital invested

Capital invested by funds: $36.2M → $19.2M (-$17M)

Holders
35
Holders Change
+1
Holders Change %
+2.94%
% of All Funds
0.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
14
Reduced
10
Closed
7
Calls
$35K
Puts
–
Net Calls
+$35K
Net Calls Change
-$24K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$210K
2
Two Sigma Advisers
Two Sigma Advisers
New York
+$191K
3
BFM
Boothbay Fund Management
New York
+$187K
4
CC
Caxton Corporation
New Jersey
+$182K
5
Two Sigma Investments
Two Sigma Investments
New York
+$176K

Top Sellers

Rank Fund Capital Flow
1
APM
Avidity Partners Management
Texas
-$2.76M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$748K
3
Millennium Management
Millennium Management
New York
-$583K
4
SCM
Stonepine Capital Management
Oregon
-$452K
5
Squarepoint
Squarepoint
New York
-$248K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
26
Citadel Advisors
Florida
$30K -$30.2K -333 -41%
PAG
27
Private Advisor Group
New Jersey
$30K – – –
Morgan Stanley
28
Morgan Stanley
New York
$15K +$454 +5 +2%
Osaic Holdings
29
Osaic Holdings
Arizona
$13K +$16.3K +180 +643%
Citigroup
30
Citigroup
New York
$12K +$16.9K +186 New
TRCT
31
Tower Research Capital (TRC)
New York
$12K +$17.2K +190 New
UBS Group
32
UBS Group
Switzerland
$7K +$6.26K +69 +144%
Royal Bank of Canada
33
Royal Bank of Canada
Ontario, Canada
$3K -$2.54K -28 -38%
SCM
34
Stonepine Capital Management
Oregon
– -$452K -4,308 Closed
Squarepoint
35
Squarepoint
New York
– -$248K -2,365 Closed
ECM
36
ExodusPoint Capital Management
New York
– -$155K -1,480 Closed
T. Rowe Price Associates
37
T. Rowe Price Associates
Maryland
– -$54K -518 Closed
SFS
38
Sowell Financial Services
Arkansas
– -$13K -147 Closed
Barclays
39
Barclays
United Kingdom
– -$4K -40 Closed
WAP
40
Wealthcare Advisory Partners
Pennsylvania
– -$1K -7 Closed
Bank of America
41
Bank of America
North Carolina
– +$91 +1 +14%
1
2

ONCS Hedge Fund Activity: Q2 2021 in Review

35 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q2 2021, worth a combined $19.2M — down 47% from $36.2M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new ONCS positions and 7 closed out — a net gain of 1 holder — while 14 added to existing stakes and 10 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $210K. The largest seller was Avidity Partners Management, cutting an estimated $2.76M.

  • 35 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q2 2021, up from 34 in Q1 2021.
  • Funds reported $19.2M of OncoSec Medical Incorporated stock for Q2 2021, down 47% quarter-over-quarter.
  • 8 funds opened new OncoSec Medical Incorporated positions in Q2 2021 and 7 closed out, a net change of +1 holder.
  • The largest OncoSec Medical Incorporated buyer in Q2 2021 was Renaissance Technologies, an estimated $210K added.
  • The largest OncoSec Medical Incorporated seller in Q2 2021 was Avidity Partners Management, an estimated $2.76M sold.

Based on aggregated 13F filings for Q2 2021.